Omada Health (OMDA) vs SOPHiA GENETICS SA (SOPH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
SOPHiA GENETICS SA (SOPH) has outperformed Omada Health (OMDA) over the past year, gaining 71.9% versus a loss of 10.3%. Omada Health is the larger company by market cap ($1.28 billion vs $608.7 million), about 2.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | OMDA | SOPH |
|---|---|---|
| Share price | $20.89 | $7.15 |
| Market cap | $1.28B | $608.66M |
| 1-day change | +0.77% | -3.12% |
| YTD return | +32.38% | +53.10% |
| 1-year return | -10.34% | +71.88% |
| 5-year return | — | -55.59% |
| P/E ratio (TTM) | 87.04 | — |
| Forward P/E | 37.56 | — |
| EPS (TTM) | $0.24 | $-1.16 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $26.92 | $8.98 |
| 52-week low | $10.28 | $3.75 |
| Distance from 52-week high | -22.39% | -20.38% |
| Analyst consensus | buy | none |
| Avg. price target upside | +36.05% | +36.36% |
| Average volume | 1.38M | 545.93K |
| Shares outstanding | 61.22M | 85.13M |
| Employees | 946 | 415 |
| Sector | Health Care | Technology |
| Industry | Medical/Nursing Services | EDP Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Omada Health is about 2.1 times larger than SOPHiA GENETICS SA by market value ($1.28B vs $608.66M).
- SOPH has outperformed OMDA by 82.2 percentage points over the past year.
- The two companies sit in different sectors: Omada Health in Health Care and SOPHiA GENETICS SA in Technology.
About Omada Health
OMDA stock →Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs.
Health Care · Medical/Nursing Services · 946 employees
About SOPHiA GENETICS SA
SOPH stock →SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities.
Technology · EDP Services · 415 employees
OMDA vs SOPH FAQ
Which is bigger, Omada Health or SOPHiA GENETICS SA?
Omada Health (OMDA) is larger, with a market capitalization of $1.28B compared with $608.66M for SOPHiA GENETICS SA (SOPH).
Which stock has performed better over the past year, OMDA or SOPH?
SOPH returned +71.88% over the past 12 months, compared with -10.34% for OMDA (price return, excluding dividends). Past performance does not predict future results.
Are Omada Health and SOPHiA GENETICS SA in the same industry?
No. Omada Health is in the Health Care sector, while SOPHiA GENETICS SA is in Technology.